These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24921652)

  • 1. Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
    Rowehl RA; Burke S; Bialkowska AB; Pettet DW; Rowehl L; Li E; Antoniou E; Zhang Y; Bergamaschi R; Shroyer KR; Ojima I; Botchkina GI
    PLoS One; 2014; 9(6):e99091. PubMed ID: 24921652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines.
    Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA
    Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs.
    Rao GH; Liu HM; Li BW; Hao JJ; Yang YL; Wang MR; Wang XH; Wang J; Jin HJ; Du L; Chen Q
    Acta Pharmacol Sin; 2013 Jun; 34(6):793-804. PubMed ID: 23736004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of chemotherapy-enriched sphere-forming cells with stemness phenotypes as a new cell line (BAG
    Bagheri V; Gholamin M; Mansouri A; Abbaszadegan MR
    Med Oncol; 2022 Sep; 39(12):201. PubMed ID: 36175578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
    Cao L; Zhou Y; Zhai B; Liao J; Xu W; Zhang R; Li J; Zhang Y; Chen L; Qian H; Wu M; Yin Z
    BMC Gastroenterol; 2011 Jun; 11():71. PubMed ID: 21669008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
    Kanwal R; Shukla S; Walker E; Gupta S
    Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.
    Mukohyama J; Isobe T; Hu Q; Hayashi T; Watanabe T; Maeda M; Yanagi H; Qian X; Yamashita K; Minami H; Mimori K; Sahoo D; Kakeji Y; Suzuki A; Dalerba P; Shimono Y
    Cancer Res; 2019 Oct; 79(20):5151-5158. PubMed ID: 31416845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer.
    Wahab SMR; Islam F; Gopalan V; Lam AK
    Clin Colorectal Cancer; 2017 Jun; 16(2):93-102. PubMed ID: 28237538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.
    Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4.
    Volonté A; Di Tomaso T; Spinelli M; Todaro M; Sanvito F; Albarello L; Bissolati M; Ghirardelli L; Orsenigo E; Ferrone S; Doglioni C; Stassi G; Dellabona P; Staudacher C; Parmiani G; Maccalli C
    J Immunol; 2014 Jan; 192(1):523-32. PubMed ID: 24277698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.